Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Brevan Howard Capital Management »

Iteos Therapeutics shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Iteos Therapeutics (ITOS) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Iteos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iteos Therapeutics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Iteos Therapeutics by Brevan Howard Capital Management

Quarter filed	Position value	Share count	Share price at filing
2023-12-31	$249k	23k	10.95

More positions owned by Brevan Howard Capital Management

Ishares Msci Emerging Mkt In Msci Emg Mkt Etf (EEM)

Financial Select Sector Spdr Financial Call Option (XLF)

Ishares Iboxx H/y Corp Bond Iboxx Hi Yd Etf Call Option (HYG)

Invesco QQQ Trust Series 1 Nasdaq100 BB:QQQ Unit Ser 1 (QQQ)

Ishares Msci Eafe Index Fund Msci Eafe Etf Call Option (EFA)

Consumer Staples Spdr Sbi Cons Stpls Call Option (XLP)

Ishares Russell 2000 Etf Russell 2000 Etf Call Option (IWM)

Health Care Select Secto Sbi Heathcare Call Option (XLV)

ISHARES 20plus YR TREAS 20 Yr Tr Bd Etf Call Option (TLT)

Spdr S&p Biotech Etf S&p Biotech Call Option (XBI)

Energy Select Sector Spdr Energy Call Option (XLE)

Spdr Metals & Mining Etf S&p Metals Mng Call Option (XME)

Streettracks Gold Trust Gold Shs Call Option (GLD)

SEMICONDUCTOR HOLDRs TRUST Semiconductr Etf (SMH)

View all positions for Brevan Howard Capital Management

Top funds holding Iteos Therapeutics

RA Capital Management

MPM Asset Management

MPM Oncology Impact Management

Citadel Advisors

Millennium Management

Dimensional Fund Advisors

Deerfield Management Company

Goldman Sachs Group

683 Capital Management

View all funds holding Iteos Therapeutics

© 2024 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z